High‐grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?

被引：0
|
作者：
Niels J. Rupp
Constanze Nemes
Elisabeth J. Rushing
Gerhard F. Huber
Sandra N. Freiberger
机构：
[1] University Hospital and University of Zurich,Department of Pathology and Molecular Pathology
[2] Cantonal Hospital St. Gallen,Institute of Pathology
[3] University Hospital and University of Zurich,Department of Neuropathology
[4] Cantonal Hospital St. Gallen,Department of Otorhinolaryngology, Head and Neck Surgery
来源：
Head and Neck Pathology | 2021年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1082 / 1084
页数：2
相关论文
共 50 条
  • [21] Pan-Trk Immunoreactivity, ETV6-NTRK3 Fusion Variants and RET Rearrangement in Salivary Secretory Carcinoma
    Yamamoto, Hidetaka
    Nozaki, Yui
    Oda, Yoshinao
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1241 - 1241
  • [22] Pan-Trk Immunoreactivity, ETV6-NTRK3 Fusion Variants and RET Rearrangement in Salivary Secretory Carcinoma
    Yamamoto, Hidetaka
    Nozaki, Yui
    Oda, Yoshinao
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1241 - 1241
  • [23] Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion
    Xu, Bin
    Al Rasheed, Mohamed R. Haroon
    Antonescu, Cristina R.
    Alex, Deepu
    Frosina, Denise
    Ghossein, Ronald
    Jungbluth, Achim A.
    Katabi, Nora
    HISTOPATHOLOGY, 2020, 76 (03) : 375 - 382
  • [24] Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST
    Brenca, Monica
    Rossi, Sabrina
    Polano, Maurizio
    Gasparotto, Daniela
    Zanatta, Lucia
    Racanelli, Dominga
    Valori, Laura
    Lamon, Stefano
    Dei Tos, Angelo Paolo
    Maestro, Roberta
    JOURNAL OF PATHOLOGY, 2016, 238 (04): : 543 - 549
  • [25] Expression of the ETV6-NTRK3 gene fusion in human secretory breast carcinoma
    Makretsov, N
    Huntsman, D
    Tognon, C
    Melnik, N
    Sorensen, PHB
    LABORATORY INVESTIGATION, 2003, 83 (01) : 297A - 297A
  • [26] Expression of the ETV6-NTRK3 gene fusion in human secretary breast carcinoma
    Makretsov, N
    Huntsman, D
    Tognon, C
    Melnik, N
    Sorensen, PHB
    MODERN PATHOLOGY, 2003, 16 (01) : 297A - 297A
  • [27] Utility of Pan-TRK Immunohistochemistry (IHC) as an Ancillary Tool in Diagnosing Secretory Carcinoma (SC) of Salivary Gland and Detecting ETV6-NTRK3 fusion
    Al Rasheed, Mohamed Rizwan Haroon
    Xu, Bin
    Antonescu, Cristina
    Alex, Deepu
    Frosina, Denise
    Ghossein, Ronald
    Jungbluth, Achim
    Katabi, Nora
    LABORATORY INVESTIGATION, 2019, 99
  • [28] Utility of Pan-TRK Immunohistochemistry (IHC) as an Ancillary Tool in Diagnosing Secretory Carcinoma (SC) of Salivary Gland and Detecting ETV6-NTRK3 fusion
    Al Rasheed, Mohamed Rizwan Haroon
    Xu, Bin
    Antonescu, Cristina
    Alex, Deepu
    Frosina, Denise
    Ghossein, Ronald
    Jungbluth, Achim
    Katabi, Nora
    MODERN PATHOLOGY, 2019, 32
  • [29] Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
    Kralik, Johanna M.
    Kranewitter, Wolfgang
    Boesmueller, Hans
    Marschon, Renate
    Tschurtschenthaler, Gertraud
    Rumpold, Holger
    Wiesinger, Kurt
    Erdel, Martin
    Petzer, Andreas L.
    Webersinke, Gerald
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [30] Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion
    Keddy, Clare
    Neff, Tanaya
    Huan, Jianya
    Nickerson, Joshua P.
    Beach, Catherine Z.
    Akkari, Yassmine
    Ji, Jianling
    Moore, Stephen
    Nazemi, Kellie J.
    Corless, Christopher L.
    Beadling, Carol
    Woltjer, Randy
    Cho, Yoon-Jae
    Wood, Matthew D.
    Davare, Monika A.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2021, 7 (05):
12345